Sangart
A biopharmaceutical company developing scientific, clinical and commercial oxygen-therapeutic agents
2
Funding Rounds
$150.0m
Money raised
Overview
A biopharmaceutical company developing scientific, clinical and commercial oxygen-therapeutic agents
- Website:
Funding
Funding series
Funding Series Analysis
The company Sangart has raised a total of $150m in funding over 2 rounds.
Key Insights:
- Sangart funding round, April 2011: $50m
- Sangart Series F round: $100m
Sangart funding round, April 2011
$50m
Sangart Series F round
$100m
Industries
Sangart is active in the following industries: